 | • レポートコード：MRC23Q35860 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のCasヌクレアーゼ市場について調査・分析し、世界のCasヌクレアーゼ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（Cas9、Cas12、Cas13、その他）、用途別セグメント分析（遺伝子編集細胞株構築、動物モデル、バイオ農業、遺伝子治療、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、GenScript、Integrated DNA Technologies, Inc.、Aldevron、Merck、Horizon Discovery、Agilent、OriGene Technologies, Inc、New England Biolabs、NIPPON GENE CO., LTD.、Novoprotein、Applied Biological Materials Inc. (abm)などが含まれています。 世界のCasヌクレアーゼ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、Casヌクレアーゼ市場規模を推定する際に考慮しました。本レポートは、Casヌクレアーゼの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、Casヌクレアーゼに関するビジネス上の意思決定に役立てることを目的としています。 ・Casヌクレアーゼ市場の概要 - Casヌクレアーゼのタイプ別セグメント - 世界のCasヌクレアーゼ市場規模：タイプ別分析（Cas9、Cas12、Cas13、その他） - Casヌクレアーゼの用途別セグメント - 世界のCasヌクレアーゼ市場規模：用途別分析（遺伝子編集細胞株構築、動物モデル、バイオ農業、遺伝子治療、その他） - 世界のCasヌクレアーゼ市場規模予測（2018年-2029年） ・Casヌクレアーゼ市場の成長トレンド - Casヌクレアーゼの地域別市場規模（2018年-2029年） - Casヌクレアーゼ市場ダイナミクス - Casヌクレアーゼの業界動向 - Casヌクレアーゼ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：Cas9、Cas12、Cas13、その他 - 世界のCasヌクレアーゼのタイプ別市場規模（2018年-2023年） - 世界のCasヌクレアーゼのタイプ別市場規模（2024年-2029年） ・用途別セグメント：遺伝子編集細胞株構築、動物モデル、バイオ農業、遺伝子治療、その他 - 世界のCasヌクレアーゼの用途別市場規模（2018年-2023年） - 世界のCasヌクレアーゼの用途別市場規模（2024年-2029年） ・Casヌクレアーゼの地域別市場規模 - 北米のCasヌクレアーゼ市場規模（2018年-2029年） - アメリカのCasヌクレアーゼ市場規模（2018年-2029年） - ヨーロッパのCasヌクレアーゼ市場規模（2018年-2029年） - アジア太平洋のCasヌクレアーゼ市場規模（2018年-2029年） - 中国のCasヌクレアーゼ市場規模（2018年-2029年） - 日本のCasヌクレアーゼ市場規模（2018年-2029年） - 韓国のCasヌクレアーゼ市場規模（2018年-2029年） - インドのCasヌクレアーゼ市場規模（2018年-2029年） - オーストラリアのCasヌクレアーゼ市場規模（2018年-2029年） - 中南米のCasヌクレアーゼ市場規模（2018年-2029年） - 中東・アフリカのCasヌクレアーゼ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、GenScript、Integrated DNA Technologies, Inc.、Aldevron、Merck、Horizon Discovery、Agilent、OriGene Technologies, Inc、New England Biolabs、NIPPON GENE CO., LTD.、Novoprotein、Applied Biological Materials Inc. (abm) ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Cas Nuclease market was valued at US$ 188.3 million in 2022 and is anticipated to reach US$ 821.1 million by 2029, witnessing a CAGR of 27.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cas Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cas Nuclease.
The Cas Nuclease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cas Nuclease market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cas Nuclease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cas Nuclease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cas Nuclease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cas9
1.2.3 Cas12
1.2.4 Cas13
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cas Nuclease Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Gene Editing Cell Line Construction
1.3.3 Animal Models
1.3.4 Bioagriculture
1.3.5 Gene Therapy
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cas Nuclease Market Perspective (2018-2029)
2.2 Cas Nuclease Growth Trends by Region
2.2.1 Global Cas Nuclease Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cas Nuclease Historic Market Size by Region (2018-2023)
2.2.3 Cas Nuclease Forecasted Market Size by Region (2024-2029)
2.3 Cas Nuclease Market Dynamics
2.3.1 Cas Nuclease Industry Trends
2.3.2 Cas Nuclease Market Drivers
2.3.3 Cas Nuclease Market Challenges
2.3.4 Cas Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cas Nuclease Players by Revenue
3.1.1 Global Top Cas Nuclease Players by Revenue (2018-2023)
3.1.2 Global Cas Nuclease Revenue Market Share by Players (2018-2023)
3.2 Global Cas Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cas Nuclease Revenue
3.4 Global Cas Nuclease Market Concentration Ratio
3.4.1 Global Cas Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cas Nuclease Revenue in 2022
3.5 Cas Nuclease Key Players Head office and Area Served
3.6 Key Players Cas Nuclease Product Solution and Service
3.7 Date of Enter into Cas Nuclease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cas Nuclease Breakdown Data by Type
4.1 Global Cas Nuclease Historic Market Size by Type (2018-2023)
4.2 Global Cas Nuclease Forecasted Market Size by Type (2024-2029)
5 Cas Nuclease Breakdown Data by Application
5.1 Global Cas Nuclease Historic Market Size by Application (2018-2023)
5.2 Global Cas Nuclease Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cas Nuclease Market Size (2018-2029)
6.2 North America Cas Nuclease Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cas Nuclease Market Size by Country (2018-2023)
6.4 North America Cas Nuclease Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cas Nuclease Market Size (2018-2029)
7.2 Europe Cas Nuclease Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cas Nuclease Market Size by Country (2018-2023)
7.4 Europe Cas Nuclease Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cas Nuclease Market Size (2018-2029)
8.2 Asia-Pacific Cas Nuclease Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cas Nuclease Market Size by Region (2018-2023)
8.4 Asia-Pacific Cas Nuclease Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cas Nuclease Market Size (2018-2029)
9.2 Latin America Cas Nuclease Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cas Nuclease Market Size by Country (2018-2023)
9.4 Latin America Cas Nuclease Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cas Nuclease Market Size (2018-2029)
10.2 Middle East & Africa Cas Nuclease Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cas Nuclease Market Size by Country (2018-2023)
10.4 Middle East & Africa Cas Nuclease Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cas Nuclease Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cas Nuclease Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Cas Nuclease Introduction
11.2.4 GenScript Revenue in Cas Nuclease Business (2018-2023)
11.2.5 GenScript Recent Development
11.3 Integrated DNA Technologies, Inc.
11.3.1 Integrated DNA Technologies, Inc. Company Detail
11.3.2 Integrated DNA Technologies, Inc. Business Overview
11.3.3 Integrated DNA Technologies, Inc. Cas Nuclease Introduction
11.3.4 Integrated DNA Technologies, Inc. Revenue in Cas Nuclease Business (2018-2023)
11.3.5 Integrated DNA Technologies, Inc. Recent Development
11.4 Aldevron
11.4.1 Aldevron Company Detail
11.4.2 Aldevron Business Overview
11.4.3 Aldevron Cas Nuclease Introduction
11.4.4 Aldevron Revenue in Cas Nuclease Business (2018-2023)
11.4.5 Aldevron Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cas Nuclease Introduction
11.5.4 Merck Revenue in Cas Nuclease Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Detail
11.6.2 Horizon Discovery Business Overview
11.6.3 Horizon Discovery Cas Nuclease Introduction
11.6.4 Horizon Discovery Revenue in Cas Nuclease Business (2018-2023)
11.6.5 Horizon Discovery Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent Cas Nuclease Introduction
11.7.4 Agilent Revenue in Cas Nuclease Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 OriGene Technologies, Inc
11.8.1 OriGene Technologies, Inc Company Detail
11.8.2 OriGene Technologies, Inc Business Overview
11.8.3 OriGene Technologies, Inc Cas Nuclease Introduction
11.8.4 OriGene Technologies, Inc Revenue in Cas Nuclease Business (2018-2023)
11.8.5 OriGene Technologies, Inc Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Cas Nuclease Introduction
11.9.4 New England Biolabs Revenue in Cas Nuclease Business (2018-2023)
11.9.5 New England Biolabs Recent Development
11.10 NIPPON GENE CO., LTD.
11.10.1 NIPPON GENE CO., LTD. Company Detail
11.10.2 NIPPON GENE CO., LTD. Business Overview
11.10.3 NIPPON GENE CO., LTD. Cas Nuclease Introduction
11.10.4 NIPPON GENE CO., LTD. Revenue in Cas Nuclease Business (2018-2023)
11.10.5 NIPPON GENE CO., LTD. Recent Development
11.11 Novoprotein
11.11.1 Novoprotein Company Detail
11.11.2 Novoprotein Business Overview
11.11.3 Novoprotein Cas Nuclease Introduction
11.11.4 Novoprotein Revenue in Cas Nuclease Business (2018-2023)
11.11.5 Novoprotein Recent Development
11.12 Applied Biological Materials Inc. (abm)
11.12.1 Applied Biological Materials Inc. (abm) Company Detail
11.12.2 Applied Biological Materials Inc. (abm) Business Overview
11.12.3 Applied Biological Materials Inc. (abm) Cas Nuclease Introduction
11.12.4 Applied Biological Materials Inc. (abm) Revenue in Cas Nuclease Business (2018-2023)
11.12.5 Applied Biological Materials Inc. (abm) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details